Rocket Lab USA is trading 4.37% down at $64.32, appearing consistent with profit-taking and uncertainty over regulatory approval, financing, and deal execution.
- It reverses part of the 6.47% September 17 gain, following FCC acceptance of license-transfer applications for the proposed Iridium acquisition—a procedural step opening public comments, not approval.
- No clear new negative company-specific catalyst emerged September 18; broader markets are modestly lower.
- It fell despite joining the Space Data Network Consortium, which does not explain the drop.